MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health

MVT
Mar 29, 2018
1 min read

Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.